Broncus Medical Inc., (HKG: 2216) a leading provider of lung disease precision intervention solutions based in China, has joined forces with Venus Medtech (Hangzhou) Inc., another prominent player in the medical field (HKG: 2500), to announce the establishment of a partnership fund. Each company is contributing RMB 125 million (USD 18.1 million) for a 24.75% stake in the venture, marking a significant step in the digital medical equipment industry.
Private Equity Fund Targets Digital Medical Equipment Growth
The newly established fund, a private equity entity, is dedicated to capitalizing on the structural growth opportunities within the digital medical equipment sector in the Greater China region. This strategic move is anticipated to expand the business ecosystems and value chains of both Broncus Medical and Venus Medtech, as well as to enrich their investment portfolios.
Enhancing Market Positions and Capital Appreciation
The partnership is not only a financial investment but also a strategic play to achieve potential capital appreciation and strengthen the market positions of both companies within the medical equipment and related industries. The fund is poised to identify and support innovative projects that align with the growing demands of the digital medical equipment market.-Fineline Info & Tech
